From physiology to pharmacy

Developments in the pathogenesis and treatment of recurrent urinary tract infections

Jennifer A. Silverman, Henry L. Schreiber IV, Thomas Hooton, Scott J. Hultgren

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Urinary tract infections (UTIs) are common, and over half of women report having had at least one in their lifetime. Nearly a third of these women experience recurrent UTI episodes, but the mechanisms of these recurrences are not fully elucidated. Frequent use of antimicrobials for treatment and prevention of UTIs and other infections has contributed to the evolution of multidrug-resistant microorganisms globally. This is a looming worldwide crisis that has created an urgent need for novel strategies for the treatment and prevention of UTIs. Furthering our understanding of the mechanisms of recurrent UTIs, from both host and bacterial perspectives, will be paramount in developing targeted management strategies. In this review, we discuss recent findings regarding recurrent UTIs in women, including progress in our understanding of the mechanisms of recurrence as well as emerging treatments.

Original languageEnglish
Pages (from-to)448-456
Number of pages9
JournalCurrent Urology Reports
Volume14
Issue number5
DOIs
StatePublished - Oct 1 2013

Fingerprint

Urinary Tract Infections
Therapeutics
Recurrence
Infection

Keywords

  • Antibiotic resistance
  • FimH
  • Mannoside
  • Pilicide
  • Recurrent urinary tract infection
  • Stress response

ASJC Scopus subject areas

  • Urology

Cite this

From physiology to pharmacy : Developments in the pathogenesis and treatment of recurrent urinary tract infections. / Silverman, Jennifer A.; Schreiber IV, Henry L.; Hooton, Thomas; Hultgren, Scott J.

In: Current Urology Reports, Vol. 14, No. 5, 01.10.2013, p. 448-456.

Research output: Contribution to journalArticle

Silverman, Jennifer A. ; Schreiber IV, Henry L. ; Hooton, Thomas ; Hultgren, Scott J. / From physiology to pharmacy : Developments in the pathogenesis and treatment of recurrent urinary tract infections. In: Current Urology Reports. 2013 ; Vol. 14, No. 5. pp. 448-456.
@article{48ed14586647474581b2085331fd4cf6,
title = "From physiology to pharmacy: Developments in the pathogenesis and treatment of recurrent urinary tract infections",
abstract = "Urinary tract infections (UTIs) are common, and over half of women report having had at least one in their lifetime. Nearly a third of these women experience recurrent UTI episodes, but the mechanisms of these recurrences are not fully elucidated. Frequent use of antimicrobials for treatment and prevention of UTIs and other infections has contributed to the evolution of multidrug-resistant microorganisms globally. This is a looming worldwide crisis that has created an urgent need for novel strategies for the treatment and prevention of UTIs. Furthering our understanding of the mechanisms of recurrent UTIs, from both host and bacterial perspectives, will be paramount in developing targeted management strategies. In this review, we discuss recent findings regarding recurrent UTIs in women, including progress in our understanding of the mechanisms of recurrence as well as emerging treatments.",
keywords = "Antibiotic resistance, FimH, Mannoside, Pilicide, Recurrent urinary tract infection, Stress response",
author = "Silverman, {Jennifer A.} and {Schreiber IV}, {Henry L.} and Thomas Hooton and Hultgren, {Scott J.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1007/s11934-013-0354-5",
language = "English",
volume = "14",
pages = "448--456",
journal = "Current Urology Reports",
issn = "1527-2737",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - From physiology to pharmacy

T2 - Developments in the pathogenesis and treatment of recurrent urinary tract infections

AU - Silverman, Jennifer A.

AU - Schreiber IV, Henry L.

AU - Hooton, Thomas

AU - Hultgren, Scott J.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Urinary tract infections (UTIs) are common, and over half of women report having had at least one in their lifetime. Nearly a third of these women experience recurrent UTI episodes, but the mechanisms of these recurrences are not fully elucidated. Frequent use of antimicrobials for treatment and prevention of UTIs and other infections has contributed to the evolution of multidrug-resistant microorganisms globally. This is a looming worldwide crisis that has created an urgent need for novel strategies for the treatment and prevention of UTIs. Furthering our understanding of the mechanisms of recurrent UTIs, from both host and bacterial perspectives, will be paramount in developing targeted management strategies. In this review, we discuss recent findings regarding recurrent UTIs in women, including progress in our understanding of the mechanisms of recurrence as well as emerging treatments.

AB - Urinary tract infections (UTIs) are common, and over half of women report having had at least one in their lifetime. Nearly a third of these women experience recurrent UTI episodes, but the mechanisms of these recurrences are not fully elucidated. Frequent use of antimicrobials for treatment and prevention of UTIs and other infections has contributed to the evolution of multidrug-resistant microorganisms globally. This is a looming worldwide crisis that has created an urgent need for novel strategies for the treatment and prevention of UTIs. Furthering our understanding of the mechanisms of recurrent UTIs, from both host and bacterial perspectives, will be paramount in developing targeted management strategies. In this review, we discuss recent findings regarding recurrent UTIs in women, including progress in our understanding of the mechanisms of recurrence as well as emerging treatments.

KW - Antibiotic resistance

KW - FimH

KW - Mannoside

KW - Pilicide

KW - Recurrent urinary tract infection

KW - Stress response

UR - http://www.scopus.com/inward/record.url?scp=84886772177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886772177&partnerID=8YFLogxK

U2 - 10.1007/s11934-013-0354-5

DO - 10.1007/s11934-013-0354-5

M3 - Article

VL - 14

SP - 448

EP - 456

JO - Current Urology Reports

JF - Current Urology Reports

SN - 1527-2737

IS - 5

ER -